Objective: To examine whether there is an association between the quality of epilepsy care, as measured by the Quality and Outcomes Framework of the 2004 General Practitioner contract for England, practice population deprivation status and epilepsy-related emergency hospitalisation. Methods: Linear regression analysis was used to examine the association between the proportion of epilepsy-treated seizure-free patients and the proportion of epilepsytreated patients with at least one epilepsy-related emergency hospitalisation at the individual practice level, adjusting for practice population deprivation status. The analysis was subsequently repeated by using the rate of epilepsy-related hospitalisations among epilepsy-treated patients (as opposed to the number of patients with at least one hospitalisation), during the same study period. Results: After adjusting for practice population deprivation status, there was a significant inverse association between the proportion of epilepsy-treated seizurefree patients and the proportion of epilepsy-treated patients with at least one epilepsy-related emergency hospitalisation. For every 1% increase in the proportion of seizure-free epilepsy-treated patients there was a 0.43% reduction in the number of patients with at least one epilepsy-related emergency hospitalisation (95% Confidence Interval: À0.09 to À0.78, p: 0.014). Discussion: The findings indicate a significant and relatively strong relationship between the quality of epilepsy management in primary care (proportion of sei-* Corresponding author.
Introduction
In England and Wales, most general practitioners (GPs) are employed by the government as independent contractors. A revised General Medical Services (GMS) contract for GPs was introduced in April 2004 (http://www.dh.gov.uk/PolicyAndGuidance/ OrganisationPolicy/PrimaryCare/PrimaryCareContracting/fs/en accessed January 2007). The new contract linked the GPs income to the quality of care provided for several chronic diseases. Quality of care is measured using a number of indicators included in the Quality and Outcomes Framework (QOF) relating to ten different chronic disease groups, including epilepsy (see Box 1) . General practices are financially rewarded for achieving a high number of ''points'' against the quality indicators. Importantly, measurement of quality indicators largely relies on own assessment of achievement of relevant processes or outcomes of care, by GPs and other general practice staff. Participation in the post-2004 GMS contract is voluntary. 1 For most quality indicators, the numerator represents a count of the number of patients for whom a clinical indicator has been met and the denominator is a count of all patients with the related condition. However, the denominator may not always be the same as the number of patients on the disease register as practices are able to exclude patients with the use of an ''exception code''. Anecdotally, in the case of ''Epilepsy Quality Indicator 4'' (see Box 1) most patients are excluded on the basis of already receiving the maximum tolerated doses of anti-convulsant therapy.
Although QOF care quality indicators are evidence-based and clearly relevant to quality improvement in processes of care 2, 3 whether they are also associated with improvement in more distant care outcomes, such as hospitalisation for epilepsy, is uncertain. Moreover, QOF does not include information on such care outcomes, for example, on emergency hospitalisations of practice patients. The relationship between processes and outcomes of care has been a long-standing subject of academic investigation 4 and previous studies have indicated that there is an association between poorseizure control and healthcare utilisation. 5 Therefore, general practices with a lower percentage of patients recorded as seizure-free could be expected to have a higher proportion of their patients admitted to acute care. Although implicit in the development of QOF is the assumption that the agreed quality indicators are true surrogate markers of care quality, direct empirical evidence about the validity of the indicators is missing. In principle, if quality indicators truly reflect the quality of care in a given disease area, an association with more distant care outcomes, such as emergency hospitalisations, should be expected. We therefore conducted a study to examine the potential association, at the practice level, between the proportion of patients aged 16 years or older on drug treatment for epilepsy declared as ''seizure-free'' for a 12-month period and epilepsy-related emergency hospitalisations in National Health Service (NHS) hospitals in Norfolk, Suffolk and Cambridgeshire. patients as the numerator and the total number of ''epilepsy-treated'' patients in the practice as the denominator. We defined every patient on drug treatment for epilepsy as ''epilepsy-treated'' (as per Epilepsy Indicator 1). This calculation overcomes any potential for systematic bias in exception reporting between different practices (see Introduction), as evidence suggests exception-reporting rates do vary across practices, although the reasons for this variation (clinical, administrative or financial) are still unclear. 6 We excluded from subsequent analysis all practices reporting a considerable change in the number of epilepsy-treated patients during the second year of implementation of the 2004 GMS contract (i.e. during the financial year [2005] [2006] . Such a change was assumed to represent an improvement in the accuracy of the practice register for epilepsy during the second year of implementation, making usage of data from the first year (financial year [2004] [2005] unreliable. Following data inspection, an arbitrary cut-off of 15% change (either increase or decrease) in the number of epilepsy-treated patients between the 2 years was used, and any practices exceeding this cut-off were excluded from subsequent analysis.
Methods
For each individual practice, the number of epilepsy-related emergency hospitalisations in an NHS hospital among practice patients aged 16 years and older within the 12-month period April 2004-March 2005 was obtained through Hospital Episodes Statistics (HES) data. Epilepsy-related emergency hospitalisations were defined as those unplanned hospital admissions for which the principal International Classification of Disease (ICD-10) diagnosis code was G40 (''epilepsy'') or G41 (''status epilepticus'').
The Indices of Multiple Deprivation (IMD) Score was used to measure practice population deprivation status. The IMD Score provides a small areabased (ecological) measurement of deprivation, using seven different domains (income, employment, health deprivation and disability, education skill and training, barriers to housing services, crime, and the living environment). IMDs are calculated at the level of small geographical areas called Super Output Areas (SOA) which have a mean population of about 1500 residents (http://www.communities.gov.uk/index.asp?id=1128444 accessed January 2007). As previously described 7, 8 practice population IMD scores were calculated by linking the practice patient population postcodes to their respective SOA IMD scores and by subsequently calculating a weighted average IMD score for each practice population.
Linear regression analysis was used to examine the association between the proportion of epilepsytreated seizure-free patients and the proportion of epilepsy-treated patients with at least one epilepsy-related emergency hospitalisation at the individual practice level, adjusting for practice population deprivation status. The analysis was subsequently repeated by using the rate of epilepsy-related hospitalisations among epilepsytreated patients (as opposed to the number of patients with at least one hospitalisation), during the same study period.
Results
Originally, data were obtained on 291 (out of a total 298) general practices in Norfolk, Suffolk and Cambridgeshire. The total 2004 mid-year resident population estimate for these three counties was 2,238,100, of whom 1,819,700 were aged 16 or older. The mean practice population size was 7750 (median 7176, Inter Quartile Range 4884).
Within the 291 general practices for which data was available, there were 14,224 epilepsy-treated patients aged 16 years and above during the study period mean number of epilepsy-treated patients per practice 48 (median 43, Inter Quartile Range 25). This translates to a prevalence rate for treated epilepsy among persons of 16 years or older of 0.78%.
There were 8592 epilepsy-treated patients aged 16 and over who were declared as seizure-free for the last 12 months (recorded in the last 15 months), representing 60.1% of the total number of epilepsytreated patients aged 16 years or older. The mean number of epilepsy-treated patients per practice recorded as seizure-free was 29 (median 27, Inter Quartile Range 15).
Of all 291 practices, 243 (84%) had less than 15% change in the number of epilepsy-treated patients between 2004-2005 and 2005-2006 . Among these practices, during the study period, there were 937 epilepsy-related emergency hospitalisations, corresponding to 718 patients. The practice population mean IMD score was 16.3 (median value of 14.3, Inter-Quartile range 10.6).
Having adjusted for practice population deprivation status, at the individual practice level, there was a significant inverse relationship between the proportion of seizure-free epilepsy patients and the proportion of epilepsy patients who had at least one epilepsy-related emergency hospitalisation: a 0.43% decrease in the proportion of patients without one or more emergency hospitalisations for every 1% increase in the seizure-free proportion (95% Confidence Interval [CI]: À0.09 to À0.78, p: 0.014, Table 1 ). Similarly, there was a significant inverse relationship between the proportion of seizure-free epilepsy patients and the rate of epilepsy-related emergency hospitalisations over the number of epilepsy-treated patients: a 0.30% decrease for every 1% increase in the seizure-free proportion (95% CI: À0.05 to À0.55, p: 0.021).
Discussion
The findings indicate that, at the individual practice level within the three counties investigated, there is a relatively strong and statistically significant relationship between the proportions of epilepsytreated patients who are declared as seizure-free and the proportion of patients with an epilepsyrelated emergency hospitalisation. In other words, the quality of care as incentivised by the QOF system appears to lead to improved outcomes in terms of minimising epilepsy-related emergency hospitalisation.
Previous research has postulated that a gap may exist between simple measures of care processes included in the QOF and the actual care quality being delivered. 9 The study findings actually challenge this thesis, providing results that should reassure patients, primary care and policy makers alike.
As this study looked at the first year of QOF implementation data errors may have been present and this might have reduced the effect size (association) between the examined variables. Unlike other recent research studies using QOF data, 6, 10 we were able to adjust for practice population deprivation status, which, as the results suggest, exerts an important independent effect on the burden of epilepsy-related emergency hospitalisations. This is consistent with the findings of other studies examining the relationship between practice QOF scores, hospitalisations and practice population deprivation. 7, 11 We were not, however, able to adjust for other important confounders, such as the age and sex ''case mix'' of practice populations, and other potentially important factors such as the proportion of epilepsy-treated patients with secondary epilepsy due to previous neurosurgery and/or trauma, and the proportion of epilepsy-treated patients with co-morbid learning disabilities.
The study assumes that the lag time between changes in the quality of processes of care (such as optimal prescription of medication and/or patient education about adherence) and seizure activity is negligible. Given the relatively rapid clearance of anti-epileptic medication this is a reasonable assumption. However, this methodology may not be readily applicable to other indicators, such as those relating to chronic cardiovascular disease, where outcomes such as hospitalisations are overall rare and mainly stochastic events. Similarly, the study does not take into account the potential for differential rates of incident epilepsy cases between participating practices -within a year some practices are bound to, randomly (i.e. independently of their quality of epilepsy care status) have a higher proportion of such incident cases than others. The incident cases may have a higher than average number of hospitalisations at the onset of their illness. This effect would have minimised the observed degree of association, but would not have introduced systematic bias.
This study has implications for future research using relatively easily available routine datasets, by providing an easily replicable methodology, which could be applied to other geographical areas, and also other chronic disease areas covered by QOF.
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Conclusion
In conclusion this study found a relatively strong and significant relationship between the routine indicators of quality of care used in QOF and an important care outcome (epilepsy-related emergency hospitalisation), supporting the current and future use of such indicators to measure the quality of epilepsy care.
